0001731122-24-000266.txt : 20240216 0001731122-24-000266.hdr.sgml : 20240216 20240216093857 ACCESSION NUMBER: 0001731122-24-000266 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220722 FILED AS OF DATE: 20240216 DATE AS OF CHANGE: 20240216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Binette Francois CENTRAL INDEX KEY: 0001940686 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38758 FILM NUMBER: 24646027 MAIL ADDRESS: STREET 1: 2022 N. ALVARADO STREET CITY: LOS ANGELES STATE: CA ZIP: 90039 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RENOVARO INC. CENTRAL INDEX KEY: 0001527728 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 452259340 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: CENTURY CITY MEDICAL PLAZA STREET 2: 2080 CENTURY CITY EAST CITY: SUITE 906 LOS ANGELES STATE: CA ZIP: 90067 BUSINESS PHONE: 45 39179840 MAIL ADDRESS: STREET 1: CENTURY CITY MEDICAL PLAZA STREET 2: 2080 CENTURY CITY EAST CITY: SUITE 906 LOS ANGELES STATE: CA ZIP: 90067 FORMER COMPANY: FORMER CONFORMED NAME: RENOVARO BIOSCIENCES INC. DATE OF NAME CHANGE: 20230807 FORMER COMPANY: FORMER CONFORMED NAME: Enochian Biosciences Inc. DATE OF NAME CHANGE: 20230804 FORMER COMPANY: FORMER CONFORMED NAME: Renovaro Biosciences Inc. DATE OF NAME CHANGE: 20230802 3/A 1 ownership.xml X0206 3/A 2022-07-22 2022-08-18 0 0001527728 RENOVARO INC. RENB 0001940686 Binette Francois C/O RENOVARO BIOSCIENCES INC. 9480 NE 2ND AVENUE #73 MIAMI FL 33131 0 1 0 0 COO and Executive VP for R&D Option to purchase shares of Common Stock 8.40 2023-04-18 2032-02-22 Common Stock 65000 D The option was inadvertently omitted from the reporting person's original Form 3, and from the Form 4 filed by the reporting person after his original Form 3 was filed. /s/ Francois Binette 2024-02-16